lessthanhalf said:
cloratheshadow said:
Thinking about swapping my Tirz for Sema. Reta has treated me well so far, and right now I’m on 8.5 mg Tirz plus 4mg Reta. I’d like to make Reta the main focus and bring Tirz down. That got me wondering…
Tirz has less GLP-1 than Sema and Reta
Tirz also has less GIP than Reta
So wouldn’t it save more money to simply replace Tirz with Reta? Reta already covers everything I need, and throwing in a little Sema for extra satiety seems like the simpler route. Sema costs almost nothing, kits run about $50.
Any reason I shouldn’t?
There is indeed a rationale against doing that. What you find online regarding receptor affinities across the various GLP drugs tends to be muddled and inconsistent. The biggest factor is who performed the measurement, the method used, and whether albumin was bound during testing (within the body, 99% of it is albumin-bound). Much of this data sits in preclinical papers under development code names, not the commercial names.
Having gone through a stack of papers on the subject, tirzepatide shows the strongest GIP agonism, not reta, and I think that is the primary explanation for why tirz has the fewest side effects among all the GLP drugs, once you adjust for how well it drives weight loss. The GIP agonism offsets many of the GLP-1 adverse effects such as nausea, vomiting, GI issues, malaise and food aversion. If reta genuinely had stronger GIP agonism than tirz, it ought to produce fewer GI side effects, and it does not.
When it comes to GLP-1 receptors, semaglutide is more potent than tirz or reta, but other factors are at play. tirz and reta are dosed higher, which narrows that gap, and tirz acts as a biased agonist at GLP-1, which lets it generate larger downstream effects from GLP-1 agonism even with lower affinity.
So in that equation, replacing tirz with sema should cut GIP agonism considerably, which would worsen the side effects coming from reta, and I doubt reta's weaker GIP agonism would do much to ease the GLP-1 side effects of sema, since reta on its own has stronger GLP-1 side effects than tirz.
So the net result would be somewhat more GLP-1 agonism, depending on dose, though even that is not 100% certain given the biased agonism point, plus far less GIP, and unchanged glucagon. That means more gastrointestinal side effects and weaker weight loss, since tirz outperforms sema at producing weight loss.
What you are already taking will outperform sema/reta, depending on your goal in rearranging them, whether that is more weight loss or fewer side effects. Raising the dose of either reta or tirz would probably curb hunger and boost weight loss, which makes the most sense and is the simplest path. If you still have substantial weight to lose, adding low dose cagri or elora is another route, but I would raise reta or tirz first, unless side effects at current doses are the issue.